Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 143.26
0.944 %
$ 14.5 B
Market Cap
38.2
P/E
NBIX - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative NBIX - Neurocrine Biosciences, Inc.
888 M
LAST VALUE
23.36%
2 YEAR CAGR
28.95%
5 YEAR CAGR
52.15%
10 YEAR CAGR